Inferra AI / Company / WOOF
Petco Health & Wellness Company, Inc.
WOOF · Consumer Discretionary
Last earnings Sep 2, 2026
AI analysis
Q2 2025 · reported Aug 28, 2025
Based on: Earnings release + parent 8-K + 10-Q — transcript not held
The event-summary record for this company carries no extracted figures, so the brief and charts cannot be drawn yet. The summary below and the held documents are the record for this event.
Guidance · company-stated
Direction: Raised
“Q2 2025 Overview • Net sales of $1.5 billion decreased 2.3% year over year in line with the company’s second quarter outlook • Comparable sales decreased 1.4% year over year • Gross profit margin expanded approximately 120 basis points to 39.3% as a percentage of net sales • Operating income improved $40.6 million to $43.0 million • GAAP net income improved $38.8 million to $14.0 million • Adjusted EBITDA 1 increased $30.3 million to $113.9 million “For the second quarter we once again delivered against our commitments, enabling us to raise our earnings outlook for the full year.”
“htm EX-99.1 EX-99.1 Exhibit 99.1 Petco Reports Second Quarter 2025 Financial Results Raises Fiscal 2025 Earnings Outlook* San Diego, August 28, 2025 – Petco (Nasdaq: WOOF) today announced its second quarter 2025 financial results.”
Classified from the release's primary full-year outlook statement.
Capital allocation
FY 2025 Outlook* Net Sales Down low single digits year over year Adjusted EBITDA $385 million to $395 million Net interest expense ~$130 million Capital Expenditures $125 million to $130 million Depreciation & Amortization ~$200 million Net Store Closures ~25 Third Quarter 2025 Outlook Q3 2025 Outlook* Net Sales Down low single digits year over year Adjusted EBITDA $92 million to $94 million 1 *Assumptions in the outlook include that economic conditions, currency rates and the tax and regulatory landscape remain generally consistent, and that current or planned tariffs on imports into the U.
Derivative Instruments The Company has entered into interest rate collar and interest rate swap agreements to limit the maximum interest on a portion of the Company s variable-rate debt and decrease its exposure to interest rate variability relating to three-month Term SOFR.
Event summary
Petco Health & Wellness Company, Inc. Q2 2025 results
Based on: Earnings release + parent 8-K + 10-Q — transcript not held
Guidance & outlook
Direction: Raised
Revenue: “Q2 2025 Overview • Net sales of $1.5 billion decreased 2.3% year over year in line with the company’s second quarter outlook • Comparable sales decreased 1.4% year over year • Gross profit margin expanded approximately 120 basis points to 39.3% as a percentage of net sales • Operating income improved $40.6 million to $43.0 million • GAAP net income improved $38.8 million to $14.0 million • Adjusted EBITDA 1 increased $30.3 million to $113.9 million “For the second quarter we once again delivered against our commitments, enabling us to raise our earnings outlook for the full year.”
Company outlook — Raised (“Raises”)
“htm EX-99.1 EX-99.1 Exhibit 99.1 Petco Reports Second Quarter 2025 Financial Results Raises Fiscal 2025 Earnings Outlook* San Diego, August 28, 2025 – Petco (Nasdaq: WOOF) today announced its second quarter 2025 financial results.”
Revenue — Raised (“increased”)
“Q2 2025 Overview • Net sales of $1.5 billion decreased 2.3% year over year in line with the company’s second quarter outlook • Comparable sales decreased 1.4% year over year • Gross profit margin expanded approximately 120 basis points to 39.3% as a percentage of net sales • Operating income improved $40.6 million to $43.0 million • GAAP net income improved $38.8 million to $14.0 million • Adjusted EBITDA 1 increased $30.3 million to $113.9 million “For the second quarter we once again delivered against our commitments, enabling us to raise our earnings outlook for the full year.”
Revenue — Raised (“raised”)
“” Full Year 2025 Outlook The company maintained its full year net sales outlook and raised its full year 2025 earnings outlook.”
Classified from the release's primary full-year outlook statement.
Capital allocation
FY 2025 Outlook* Net Sales Down low single digits year over year Adjusted EBITDA $385 million to $395 million Net interest expense ~$130 million Capital Expenditures $125 million to $130 million Depreciation & Amortization ~$200 million Net Store Closures ~25 Third Quarter 2025 Outlook Q3 2025 Outlook* Net Sales Down low single digits year over year Adjusted EBITDA $92 million to $94 million 1 *Assumptions in the outlook include that economic conditions, currency rates and the tax and regulatory landscape remain generally consistent, and that current or planned tariffs on imports into the U.
SEC original ↗Petco Health & Wellness Company, Inc. — Earnings release (8-K exhibit)EX-99Aug 28, 2025
Derivative Instruments The Company has entered into interest rate collar and interest rate swap agreements to limit the maximum interest on a portion of the Company s variable-rate debt and decrease its exposure to interest rate variability relating to three-month Term SOFR.
SEC original ↗Petco Health & Wellness Company, Inc. — 10-Q Quarterly report10-QSep 4, 2026
Senior Secured Credit Facilities The Company had a $ 1,700.0 million secured term loan facility originally maturing on March 4, 2028 (the First Lien Term Loan ).
SEC original ↗Petco Health & Wellness Company, Inc. — 10-Q Quarterly report10-QSep 4, 2026
As of January 31, 2026, the outstanding principal balance of the First Lien Term Loan was $ 1,500.0 million.
SEC original ↗Petco Health & Wellness Company, Inc. — 10-Q Quarterly report10-QSep 4, 2026
On February 2, 2026, the Company entered into a refinancing amendment to the credit agreement governing the First Lien Term Loan and issued $ 600.0 million in aggregate principal amount of senior secured notes (the Senior Secured Notes ).
SEC original ↗Petco Health & Wellness Company, Inc. — 10-Q Quarterly report10-QSep 4, 2026
Among other changes, the amendment provided that certain lenders would provide new term loans to the Company in an aggregate principal amount of $ 900.0 million (the Amended First Lien Term Loan ), the proceeds of which, together with cash on hand and the proceeds from the Company's issuance of the Senior Secured Notes, would be used to repay the then outstanding principal on the First Lien Term Loan.
SEC original ↗Petco Health & Wellness Company, Inc. — 10-Q Quarterly report10-QSep 4, 2026
Strategy & priorities
(3) Other costs include, as incurred: restructuring costs and restructuring-related severance costs; legal reserves associated with significant, non-ordinary course legal or regulatory matters; and costs related to certain significant strategic transactions.
SEC original ↗Petco Health & Wellness Company, Inc. — Earnings release (8-K exhibit)EX-99Aug 28, 2025
Forward-looking and other statements in this Form 10-Q may also address our progress, plans, and goals with respect to sustainability initiatives, and the inclusion of such statements is not an indication that these contents are necessarily material to investors or required to be disclosed in our filings with the U.
SEC original ↗Petco Health & Wellness Company, Inc. — 10-Q Quarterly report10-QSep 4, 2026
(together with its consolidated subsidiaries, the Company ) is a leading pet specialty retailer focused on improving the lives of pets, pet parents, and its own partners.
SEC original ↗Petco Health & Wellness Company, Inc. — 10-Q Quarterly report10-QSep 4, 2026
( Petco , the Company , we , our and us ) is a leading pet specialty retailer focused on improving the lives of pets, pet parents, and our own partners.
SEC original ↗Petco Health & Wellness Company, Inc. — 10-Q Quarterly report10-QSep 4, 2026
Our multicategory strategy integrates our digital assets with our nationwide physical footprint to meet the needs of pet parents who are looking for a single source for all their pets' needs.
SEC original ↗Petco Health & Wellness Company, Inc. — 10-Q Quarterly report10-QSep 4, 2026
Risks & headwinds
The Company’s third quarter and full year 2025 outlook assumes that the tariffs on imports into the U.
SEC original ↗Petco Health & Wellness Company, Inc. — Earnings release (8-K exhibit)EX-99Aug 28, 2025
FY 2025 Outlook* Net Sales Down low single digits year over year Adjusted EBITDA $385 million to $395 million Net interest expense ~$130 million Capital Expenditures $125 million to $130 million Depreciation & Amortization ~$200 million Net Store Closures ~25 Third Quarter 2025 Outlook Q3 2025 Outlook* Net Sales Down low single digits year over year Adjusted EBITDA $92 million to $94 million 1 *Assumptions in the outlook include that economic conditions, currency rates and the tax and regulatory landscape remain generally consistent, and that current or planned tariffs on imports into the U.
SEC original ↗Petco Health & Wellness Company, Inc. — Earnings release (8-K exhibit)EX-99Aug 28, 2025
Adjusted EBITDA is a non-GAAP financial measure and has not been reconciled to the most comparable GAAP outlook because it is not possible to do so without unreasonable efforts due to the uncertainty and potential variability of reconciling items, which are dependent on future events and often outside of management’s control and which could be significant.
SEC original ↗Petco Health & Wellness Company, Inc. — Earnings release (8-K exhibit)EX-99Aug 28, 2025
All forward-looking statements are based on current expectations and assumptions about future events that may or may not be correct or necessarily take place and that are by their nature subject to significant uncertainties and contingencies, many of which are outside the control of Petco.
SEC original ↗Petco Health & Wellness Company, Inc. — Earnings release (8-K exhibit)EX-99Aug 28, 2025
Petco cautions that the foregoing list of risks, uncertainties and other factors is not complete, and forward-looking statements speak only as of the date they are made.
SEC original ↗Petco Health & Wellness Company, Inc. — Earnings release (8-K exhibit)EX-99Aug 28, 2025
Legal Proceedings 26 Item 1A.
SEC original ↗Petco Health & Wellness Company, Inc. — 10-Q Quarterly report10-QSep 4, 2026
Competitors
Competitors & peers
Same GICS sector — classification peers, not declared competitors
Filings
31 documentsEarnings releases
8 documentsPresentations
0 documentsNo presentations for Petco Health & Wellness Company, Inc. are held in this edition of the library.
Transcripts
0 documentsNo transcripts for Petco Health & Wellness Company, Inc. are held in this edition of the library.
See also the earnings calendar for every tracked company’s next earnings date.